| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2811 | |||||||||||||||||||||||
| Submitter : | Mrs. Deborah Kistner | Date & Time: | 12/08/2006 09:12:44 | |||||||||||||||||||||
| Organization : | Mrs. Deborah Kistner | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| It only makes sense to utilize non-objectionable cell lines in vaccine production so that all people can benefit from them without compromising their moral beleifs and pro-life convictions. Using aboted fetal cell lines is not ethical or moral practice of the medical, pharaceutical, and scientific professions. We need to be protecting life not experimenting on it, even if the life has already been killed by another a moral procdure. | ||||||||||||||||||||||||